USL Toscana Sud Est, Grosseto, Italy.
Ann Surg Oncol. 2022 Apr;29(4):2469-2470. doi: 10.1245/s10434-021-11116-5. Epub 2021 Nov 27.
Isolated pancreatic metastasis from melanoma is extremely uncommon and accounts for approximately only 2% of visceral disseminations of melanoma. Interestingly, pancreatic localizations disproportionately derive from primary ocular melanoma. Despite the currently available evidence on this argument being scarce, the survival outcomes of patients receiving resection for visceral melanoma metastases are reported to be superior than those managed by non-surgical modalities. CASE PRESENTATION: A 59-year-old female with a history of uveal melanoma presented with surveillance-detected metastatic disease confined to the pancreas. Computed tomography demonstrated one lesion located in the body of the pancreas and one further lesion in the head. The presented video illustrates the details of an extended, ultrasound-guided, robotic distal pancreatectomy.
Metastatic ocular melanoma has a highly variable natural history, which ranges from a fulminant course to prolonged stable disease. In contrast to cutaneous melanoma derivation, metastases mostly occur via hematogenous spread, in the absence of lymphatic drainage of the eye. Liver is the most common site of secondary localization and is not involved by metastatic disease in <10% of cases. Interestingly, patients with extrahepatic metastases tend to have significantly better survival rates than those with hepatic disease. Fewer than 100 cases of pancreatic metastasis from malignant melanoma are reported in the medical literature, including a relatively high percentage of primary ocular malignancies. Furthermore, the prognosis of these patients is essentially unknown, although metastatic melanoma of both cutaneous and ocular origin generally indicates poor survival. Although no robust evidence is available, a number of reports suggest that pancreatic resection may improve survival in these patients. A large retrospective review investigating the association between treatment modalities and survival of patients with abdominal visceral melanoma metastases showed that patients receiving resection had a superior median survival compared with patients treated medically. Although patients with metastases of the gastrointestinal tract showed the best outcomes following surgery, patients with pancreas metastasis (of both cutaneous and ocular origin) undergoing resection also exhibited a significant survival advantage compared with those treated non-surgically. Minimally invasive pancreatectomy is gaining momentum. In fact, in selected patients there are distinct advantages compared with conventional surgery owing to reduced postoperative morbidity and earlier return to daily activities, while maintaining the oncological tenets of resection. Recent reports suggest that the application of robots may provide some advantages over conventional laparoscopy, especially for patients necessitating technically challenging surgeries. Such benefits are mainly in relation to the rate of conversion, length of postoperative hospital stay, and number of cases necessary to surmount the learning curve and reach optimal performance; however, no definitive conclusions can be drawn due to the lack of high-level evidence..
黑色素瘤孤立性胰腺转移极为罕见,约占黑色素瘤内脏播散的 2%。有趣的是,胰腺定位不成比例地来自原发性眼黑色素瘤。尽管目前对此论点的证据很少,但接受内脏黑色素瘤转移切除术的患者的生存结果报告优于非手术治疗方式。
一名 59 岁女性,有脉络膜黑色素瘤病史,因监测发现局限于胰腺的转移性疾病就诊。计算机断层扫描显示胰腺体部有一个病变,头部还有一个病变。本视频介绍了超声引导下机器人扩大远端胰腺切除术的细节。
眼黑色素瘤转移具有高度可变的自然病史,从暴发性病程到延长稳定疾病不等。与皮肤黑色素瘤来源不同,转移主要通过血行播散发生,而眼部没有淋巴引流。肝脏是最常见的继发性定位部位,不到 10%的病例没有肝转移。有趣的是,有肝外转移的患者的生存率明显高于有肝疾病的患者。在医学文献中报告了不到 100 例恶性黑色素瘤胰腺转移病例,包括相对较高比例的原发性眼恶性肿瘤。此外,这些患者的预后基本上是未知的,尽管皮肤和眼来源的转移性黑色素瘤通常预示着较差的生存。虽然没有确凿的证据,但一些报告表明胰腺切除术可能改善这些患者的生存。一项大型回顾性研究调查了腹部内脏黑色素瘤转移患者的治疗方式与生存之间的关系,结果表明,接受切除术的患者中位生存时间优于接受药物治疗的患者。尽管胃肠道转移患者手术后效果最好,但接受胰腺切除术(皮肤和眼来源)的胰腺转移患者与非手术治疗相比也有显著的生存优势。微创胰腺切除术正在兴起。事实上,在某些选定的患者中,由于术后发病率降低和更早恢复日常活动,与传统手术相比具有明显的优势,同时保持切除术的肿瘤学原则。最近的报告表明,机器人的应用可能比传统腹腔镜具有一些优势,特别是对于需要技术挑战性手术的患者。这些好处主要与转换率、术后住院时间和克服学习曲线达到最佳表现所需的病例数有关;然而,由于缺乏高水平的证据,因此无法得出明确的结论。